Protective Activity Induced by Oral Administration of Amphotericin B against Infections due to Candida albicans and Vaccinia Virus in Mice.

Orally administered amphotericin B (AmB) induced protective activity against infections due to vaccinia virus and Candida albicans in mice. This activity was also confirmed in immunocompromised mice. Analyses of the kinetics of peripheral blood cells treated with oral AmB indicated an increased ratio of polymorphonuclear leukocytes (PMN). Enhancement of γ-interferon (IFN) production and of NK-cell activity was also observed. The data were considered to indicate that γ-IFN produced by oral AmB has an important part as one of the factors protecting mice against both candidiasis and vaccinia virus infection.

[1]  Chien‐Ho Chen,et al.  In vivo anti-candidal activity induced by a traditional Chinese herbal medicine, Ganoderma lucidum , 1992 .

[2]  D. Stevens,et al.  Synergy between cilofungin and amphotericin B in a murine model of candidiasis , 1991, Antimicrobial Agents and Chemotherapy.

[3]  Djeu Jy.  Tumor necrosis factor and Candida albicans. , 1991 .

[4]  E. Ralph,et al.  Comparative in vitro effects of liposomal amphotericin B, amphotericin B-deoxycholate, and free amphotericin B against fungal strains determined by using MIC and minimal lethal concentration susceptibility studies and time-kill curves , 1991, Antimicrobial Agents and Chemotherapy.

[5]  J. Djeu.  Tumor necrosis factor and Candida albicans. , 1991, Behring Institute Mitteilungen.

[6]  H. M. Geller,et al.  Comparative toxicities of amphotericin B and its monomethyl ester derivative on glial cells in culture , 1990, Antimicrobial Agents and Chemotherapy.

[7]  M. Rinaldi,et al.  In vitro and in vivo activities of Sch 39304, fluconazole, and amphotericin B against Histoplasma capsulatum , 1990, Antimicrobial Agents and Chemotherapy.

[8]  D. Venzon,et al.  Effects of antifungal agents on the function of human neutrophils in vitro , 1990, Antimicrobial Agents and Chemotherapy.

[9]  W. Powderly,et al.  Amphotericin B: current understanding of mechanisms of action , 1990, Antimicrobial Agents and Chemotherapy.

[10]  M. Gorensek.  The immunocompromised host. , 1989, Dermatologic clinics.

[11]  D. Loebenberg,et al.  Comparative in vitro and in vivo evaluation of N-D-ornithyl amphotericin B methyl ester, amphotericin B methyl ester, and amphotericin B , 1987, Antimicrobial Agents and Chemotherapy.

[12]  K. Yazawa,et al.  Some New Approaches to the Evaluation of Antifungal Activities of Amphotericin B , 1987 .

[13]  Y. Mikami,et al.  Protection Activity Induced by the Bacterial Vaccine, Heat-Killed Clostridium butyricum Against Candida albicans Infections in Mice , 1987 .

[14]  R. C. Pandey,et al.  Anti-viral activity of amphotericin B methyl ester: inhibition of HTLV-III replication in cell culture. , 1986, Biochemical pharmacology.

[15]  M. S. Ching,et al.  Absorption of orally administered amphotericin B lozenges. , 1983, British journal of clinical pharmacology.

[16]  S. Cryz,et al.  Simple model for the study of Pseudomonas aeruginosa infections in leukopenic mice , 1983, Infection and immunity.

[17]  F. Odds.  Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro , 1982, Antimicrobial Agents and Chemotherapy.

[18]  G. H. Scott,et al.  Glucan-induced enhancement of host resistance to selected infectious diseases , 1980, Infection and immunity.

[19]  D. Bitter‐Suermann,et al.  Solid phase activation of alternative pathway of complement by beta-1,3-glucans and its possible role for tumour regressing activity. , 1978, Immunology.

[20]  R. Lynch,et al.  Augmentation of murine immune responses by amphotericin B. , 1977, Cellular immunology.

[21]  L. Hammarström,et al.  Mitogenic Properties of Polyene Antibiotics for Murine B Cells , 1976, Scandinavian journal of immunology.

[22]  S. Chaparas,et al.  Effects of BCG, Corynebacterium parvum, and methanol-extration residue in the reduction of mortality from Staphylococcus aureus and Candida albicans infections in immunosuppressed mice , 1975, Infection and immunity.

[23]  R. Fauve,et al.  Immunostimulation with bacterial phospholipid extracts. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[24]  G. Medoff,et al.  Changes in murine resistance to Listeria monocytogenes infection induced by amphotericin B. , 1973, The Journal of infectious diseases.